Atlas Trials

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

Clinical trial NCT03336983 · COMPLETED

Trial details

NCT number
NCT03336983
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerBone Metastases
Start date
2017-12-01
Primary completion
2022-06-30
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.